Normal Saline (Placebo): Clinical Trials

44 trials of Normal Saline (Placebo), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed, 11 recruiting, 5 not yet recruiting, 2 active not recruiting. 10 Not applicable, 10 Phase 2, 10 Phase 3, 10 Phase 4, 8 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable10Completed 7, Active not recruiting 1, Not yet recruiting 1, Terminated 1
Phase 210Completed 6, Recruiting 3, Not yet recruiting 1
Phase 310Recruiting 5, Completed 3, Not yet recruiting 1, Terminated 1
Phase 410Completed 5, Recruiting 3, Not yet recruiting 2
Phase 18Completed 5, Recruiting 2, Active not recruiting 1
Early Phase 11Recruiting 1

Follow Normal Saline (Placebo): new trials by email Literature Review of Normal Saline (Placebo) trials Research Report on Normal Saline (Placebo)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness of Single and Dual Silver Fluoride Application
38% Silver Fluoride (Riva Star Aqua), Normal Saline (Placebo) - Dentine Caries
Phase 3Not yet recruitingUniversity of Malaya1482026-10-012026-08-31
Comparison of the Efficacy of Different Analgesic Strategies for Pain Control After Laparoscopic Cholecystectomy (LC)
Low pneumoperitoneum, Local anaesthetic instillation to gallbladder bed, Normal Saline (Placebo) - Gallstones, Pain
Not applicableActive not recruitingAssiut University2002026-08-012026-10-27
SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years
NBP608 (Mid Potency), NBP608 (Low Potency), Varivax® - Varicella (Chickenpox)
Phase 3RecruitingSK Bioscience Co., Ltd.7802026-07-042026-09-15
Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery
Tranexamic Acid (Topical), Normal Saline (Placebo) - Cesarean Delivery, Postpartum Hemorrhage (PPH)
Early Phase 1RecruitingWolfson Medical Center1122026-07-012026-07-02
Effect of Ipratropium Bromide on EILO
Ipratropium Bromide, Normal Saline (Placebo) - Exercise-Induced Laryngeal Obstruction, Dyspnea During Activity
Phase 2Not yet recruitingCook Children's Health Care System502026-06-012026-05-05
rhBNP for Prevention of Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI)
Recombinant Human Brain Natriuretic Peptide (rhBNP), Normal Saline (Placebo) - AKI - Acute Kidney Injury, Cardiac Surgical Procedures
Phase 4Not yet recruitingChina National Center for Cardiovascular Diseases6942026-05-012026-06-01
Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults
Normal Saline (Placebo), PfSPZ-LARC2 Vaccine, PfSPZ Challenge (7G8) - Malaria Falciparum
Phase 1RecruitingSanaria Inc.422026-03-122026-11-03
Intra-Articular PRP Versus Dexamethasone for TMJ Internal Derangement
Platelet-Rich Plasma (PRP), Dexamethasone with Local Anaesthetic, Normal Saline (Placebo) - Temporomandibular Joint Disorders, Temporomandibular Joint Internal Derangement
Not applicableCompletedUniversity Of Anbar302025-12-102026-07-09
Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.
OnabotulinumtoxinA, Normal saline (placebo) - Base-of-thumb Osteoarthritis, Osteoarthritis
Phase 2 / Phase 3RecruitingAssistance Publique - Hôpitaux de Paris1202025-12-032026-04-03
IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study
Ferric carboxymaltose IV, Normal Saline (Placebo) - Scoliosis Correction, Iron Deficiency
Phase 2 / Phase 3RecruitingColumbia University1202025-11-212025-11-26
Effect of Dexmedetomidine on Acute Kidney Injury After Ascending Aortic Surgeries
Dexmedetomidine, Normal Saline (Placebo) - Aki After Ascending Aortic Surgeries
Phase 1Active not recruitingAin Shams University782025-11-012026-06-09
Prevention and Treatment for Bruises in Patients With Ischemic Stroke
Ascorbic acid (Vitamin C), Normal Saline (Placebo) - Stroke, Bruises
Phase 4Not yet recruitingChiayi Christian Hospital4002025-08-012025-02-13
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, Normal Saline (Placebo) - Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4RecruitingDuke University60002025-07-232026-10-29
A Phase 1/2a to Evaluate the Safety and Efficacy of Adipose Tissue Allograft (BRC-OA) in Patients With Osteoarthritis of the Knee
Cryopreserved Devitalized Adipose Tissue Allograft, Normal Saline (Placebo) - Osteoarthritis of Knee
Phase 1 / Phase 2CompletedBritecyte462025-05-052026-09-08
Application of Low-dose Muscle Relaxants in Bronchoscopic Interventional Procedures
Normal Saline (Placebo), Lidocaine Intravenous Infusion, Remimazolam Tosilate - Disease of Respiratory System
Not applicableCompletedHarbin Medical University1532025-03-142026-10-19
Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso
PfSPZ-LARC2 Vaccine, Normal Saline (Placebo) - Malaria Falciparum, Malaria Infection
Phase 1CompletedSanaria Inc.752025-03-042026-04-16
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults
GBP560-A, GBP560-B, IXIARO - Japanese Encephalitis Virus Disease
Phase 1 / Phase 2CompletedSK Bioscience Co., Ltd.1612025-02-242026-09-11
Investigating the Efficacy and Safety of Neoadjuvant Intravesical Instillation of Mitomycin C in Treating High-risk NMIBC Patients
Mitomycin C (MMC), Normal Saline (Placebo) - Non-Muscle-Invasive Bladder Cancer (NMIBC)
Phase 3RecruitingShaogang Wang1802025-02-172025-02-19
Dexmedetomidine and Bupivacaine Intra-articular for Postoperative Analgesia After Knee Arthroscopic Surgery
Normal Saline (Placebo), Bupivacaine 0.25%, Dexmedetomidine - Post Operative Analgesia
Phase 3RecruitingAl-Azhar University752024-12-012025-04-22
FMT for Insomnia Disorder (FMT-SLEEP)
Faecal Microbiota Transplantation, Normal Saline (Placebo) - Chronic Insomnia Disorder
Not applicableNot yet recruitingChinese University of Hong Kong742024-11-012024-09-23

Showing 20 of 44. Sign in to see all of them.

Conditions studied

Malaria (3)  ·  Malaria, Falciparum (3)  ·  Cerebral Palsy (2)  ·  Hemorrhage (2)  ·  Muscle Spasticity (2)  ·  Pain (2)  ·  Postpartum Hemorrhage (2)  ·  Stroke (2)  ·  Acute Kidney Injury (1)  ·  Agnosia (1)  ·  Blood Loss, Surgical (1)  ·  Brain Injuries, Traumatic (1)  ·  Cardiovascular Diseases (1)  ·  Chickenpox (1)  ·  Colonic Neoplasms (1)

Sponsors

Allergan (5)  ·  Sanaria Inc. (3)  ·  Liaquat National Hospital & Medical College (2)  ·  SK Bioscience Co., Ltd. (2)  ·  Ain Shams University (1)  ·  Al-Azhar University (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Assiut University (1)  ·  B.P. Koirala Institute of Health Sciences (1)  ·  Britecyte (1)  ·  Chiayi Christian Hospital (1)  ·  China National Center for Cardiovascular Diseases (1)  ·  Chinese University of Hong Kong (1)  ·  Columbia University (1)  ·  Cook Children's Health Care System (1)

Countries

United States (14)  ·  Canada (5)  ·  Egypt (4)  ·  Pakistan (4)  ·  Australia (3)  ·  China (3)  ·  Philippines (3)  ·  Poland (3)  ·  South Korea (3)  ·  Thailand (3)  ·  Turkey (Türkiye) (3)  ·  Hungary (2)  ·  Russia (2)  ·  Burkina Faso (1)  ·  France (1)

Top investigators

Rozalina Dimitrova (2)  ·  Alla Danilkovitch (1)  ·  Amichai Rottenstreich (1)  ·  Boris D Heifets, MD, PhD (1)  ·  Daniel A Emmert, MD PhD (1)  ·  Deborah Dudgeon, MD, FRCPC (1)  ·  Demetrios J. Kutsogiannis, MD MHS FRCPC (1)  ·  Denis E O'Donnell, MD, FRCPC (1)  ·  Eric Jacobsohn, MB ChB (1)  ·  Erin Wright, MD (1)  ·  George A Mashour, MD PhD (1)  ·  Ghulam Murtaza, MBBS, FCPS, MRCS, MSc (epi) (1)

Results publications

PMID 11573006, PMID 14671251, PMID 16078959, PMID 19003734, PMID 19558476, PMID 19874953, PMID 20083041, PMID 21916138, PMID 22569484, PMID 24284213, PMID 25185110, PMID 26140855, PMID 26694209, PMID 26756058, PMID 26988952, PMID 27230645, PMID 27745812, PMID 27843871, PMID 28576285, PMID 29040244, PMID 29438525, PMID 29766750, PMID 29943719, PMID 29995458, PMID 30232617, PMID 30336852, PMID 30524741, PMID 30589927, PMID 30768457, PMID 31610718, PMID 32045513, PMID 32681472, PMID 32754902, PMID 32809003, PMID 33517432, PMID 34448547, PMID 34495877, PMID 35131720, PMID 35164991, PMID 35306630, PMID 35852267, PMID 36156315, PMID 36762865, PMID 37205558, PMID 37278679, PMID 37806002, PMID 38188539, PMID 42432924, PMID 42800498, PMID 7787644

NIH funding

2008 (1)